AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Olaku DS 0.2% Eye Drop

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Olopatadine (0.2% w/v)

Overview Olaku DS 0.2% Eye Drop

Allergic conjunctivitis, marked by eye irritation, redness, swelling, and itching from allergens like pollen, dust, or pet dander, responds to Olaku DS 0.2% eye drops. These drops are an antihistamine, and their application should strictly adhere to your physician's directions, maintaining consistent dosing intervals. Complete the prescribed course, regardless of symptom improvement. While temporary burning or stinging might occur, this is a common, self-limiting side effect.

Uses of Olaku DS 0.2% Eye Drop

Managing Allergic Reactions

Major Benefits of Olaku DS 0.2% Eye Drop:

Apply this medication externally only. Administer as directed by your physician, adhering to the prescribed dosage and treatment schedule. Always consult the product label for application instructions. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.

Common Side effects of Olaku DS 0.2% Eye Drop:

  • Eye pain
  • Eye irritation
  • Abnormal eye sensation
  • Eye discomfort
  • Sleepiness
  • Weakness
  • Dryness in mouth

How to use Olaku DS 0.2% Eye Drop:

Apply this medication externally only. Administer as directed by your physician, adhering to the prescribed dosage and treatment period. Consult the product label for application instructions prior to use. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.

How Olaku DS 0.2% Eye Drop works:

Allergic conjunctivitis can be treated with Olaku DS 0.2% ophthalmic solution, an antihistamine eye drop. This medication inhibits histamine, a substance that triggers the symptoms of eye redness, itching, and tearing.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Olaku DS 0.2% Eye Drops during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks before recommending its use. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Olaku DS 0.2% Eye Drops while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Using Olaku DS 0.2% Eye Drops may temporarily blur your vision. Refrain from driving until your vision returns to normal.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Olaku DS 0.2% Eye Drop :

Should you forget a dose of Olaku DS 0.2% Eye Drops, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Olaku DS 0.2% Eye Drop

LabelValue
Type of Compound Dibenzoxepine-based compound
Potential for Dependence None.
Medication Category Eye drops

FAQs on Olaku DS 0.2% Eye Drop

Olaku DS 0.2% Eye Drops do not contain steroids. This medication addresses allergic conditions, primarily allergic conjunctivitis (pink eye). Always seek medical advice before using this product.
Consistent use of Olaku DS 0.2% Eye Drops, as directed by your physician, is crucial for effectiveness. Discontinuing treatment prematurely, even with symptom improvement, may lead to recurrence or exacerbation.
Olaku DS 0.2% Eye Drops typically do not irritate the eyes; instead, they often alleviate inflammation and irritation. Nevertheless, some individuals may encounter eye irritation, unusual sensations, or general discomfort.
Olaku DS 0.2% ophthalmic solution may be administered to children older than 3 years at the adult dosage. The safety and efficacy of Olaku DS 0.2% eye drops in children under 3 years have not been determined. Consequently, its use in this younger age group is not recommended.
Olaku DS 0.2% Eye Drops typically do not induce drowsiness. Nevertheless, somnolence is a potential side effect in certain individuals. Concomitant oral use of other antihistamines may increase the likelihood of sleepiness. Refrain from operating vehicles or heavy machinery if drowsiness occurs. Consult your physician if you experience any discomfort while using this medication.
Administer one drop of Olaku DS 0.2% Eye Drop into the affected eye(s) twice daily. Treatment length with Olaku DS 0.2% Eye Drop varies depending on the illness, its severity, and individual patient response. Treatment may extend up to four months if deemed appropriate by your physician, but the precise duration will be determined by your doctor.
Consistent use of Olaku DS 0.2% Eye Drops, as directed by your physician, is crucial for effectiveness. Discontinuing treatment prematurely, even with symptom improvement, may lead to recurrence or exacerbation.
Olaku DS 0.2% Eye Drops generally do not irritate the eyes; rather, they help alleviate existing inflammation and irritation. Nevertheless, some individuals may experience irritation, unusual sensations, or discomfort in the eye.
Olaku DS 0.2% ophthalmic solution may be administered to children older than 3 years at the adult dosage. The safety and efficacy of Olaku DS 0.2% ophthalmic solution in children under 3 years have not been determined. Consequently, its use in this younger age group is not recommended.
Olaku DS 0.2% Eye Drops typically do not induce drowsiness. Nevertheless, somnolence may occur in certain instances. Concurrent oral use of other antihistamines may increase the likelihood of sleepiness. Refrain from operating vehicles or heavy machinery if drowsiness develops. Consult your physician if you experience any discomfort.
Administer one drop of Olaku DS 0.2% Eye Drop into the affected eye(s) twice a day. The treatment period for Olaku DS 0.2% Eye Drop varies depending on the illness, its intensity, and the patient's progress. Treatment may extend up to four months if deemed appropriate, but the precise duration will be determined by your physician.
Allergic rhinitis, an allergic nasal inflammation, may be treated with Olaku DS 0.2% Eye Drops. This medication manages symptoms such as nasal discharge and sneezing. It's also indicated for certain skin conditions involving hives and pruritus.
Administer this medication solely as directed by your physician. The typical prescription involves one tablet twice daily, once in the morning and again following the evening meal. Your doctor will determine the precise dose and treatment length.
Olaku DS 0.2% Eye Drops are suitable for managing persistent itching, a condition known as chronic urticaria. However, a proper diagnosis of the itchy condition is necessary before commencing treatment. Your physician will determine the correct dosage and treatment length.
Olaku DS 0.2% Eye Drops may provide relief from pollen-induced hay fever (pollinosis). Consult your physician before using this treatment for hay fever. For effective pollinosis management, consider using the medication throughout the entire pollen season to minimize symptom recurrence.
Olaku DS 0.2% Eye Drop
119
MRP 145
17% off